These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 32962005)

  • 1. P2Y Purinergic Receptors, Endothelial Dysfunction, and Cardiovascular Diseases.
    Strassheim D; Verin A; Batori R; Nijmeh H; Burns N; Kovacs-Kasa A; Umapathy NS; Kotamarthi J; Gokhale YS; Karoor V; Stenmark KR; Gerasimovskaya E
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Interplay of Endothelial P2Y Receptors in Cardiovascular Health: From Vascular Physiology to Pathology.
    Cabou C; Martinez LO
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2X and P2Y nucleotide receptors as targets in cardiovascular disease.
    Kennedy C; Chootip K; Mitchell C; Syed NI; Tengah A
    Future Med Chem; 2013 Mar; 5(4):431-49. PubMed ID: 23495690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of Macrophage Inflammation by P2Y Purinergic Receptors.
    Klaver D; Thurnher M
    Cells; 2021 May; 10(5):. PubMed ID: 34064383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Jun, Foxo3a, and c-Myc Transcription Factors are Key Regulators of ATP-Mediated Angiogenic Responses in Pulmonary Artery Vasa Vasorum Endothelial Cells.
    Strassheim D; Karoor V; Nijmeh H; Weston P; Lapel M; Schaack J; Sullivan T; Dempsey EC; Stenmark KR; Gerasimovskaya E
    Cells; 2020 Feb; 9(2):. PubMed ID: 32054096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of P2Y receptors.
    von Kügelgen I
    Brain Res Bull; 2019 Sep; 151():12-24. PubMed ID: 30922852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology and structure of P2Y receptors.
    von Kügelgen I; Hoffmann K
    Neuropharmacology; 2016 May; 104():50-61. PubMed ID: 26519900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purinergic P2Y receptors: Molecular diversity and implications for treatment of cardiovascular diseases.
    Nishimura A; Sunggip C; Oda S; Numaga-Tomita T; Tsuda M; Nishida M
    Pharmacol Ther; 2017 Dec; 180():113-128. PubMed ID: 28648830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purinergic Signaling in the Cardiovascular System.
    Burnstock G
    Circ Res; 2017 Jan; 120(1):207-228. PubMed ID: 28057794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Important roles of P2Y receptors in the inflammation and cancer of digestive system.
    Wan HX; Hu JH; Xie R; Yang SM; Dong H
    Oncotarget; 2016 May; 7(19):28736-47. PubMed ID: 26908460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purinergic signaling via P2Y receptors up-mediates IL-6 production by liver macrophages/Kupffer cells.
    Ishimaru M; Yusuke N; Tsukimoto M; Harada H; Takenouchi T; Kitani H; Kojima S
    J Toxicol Sci; 2014 Jun; 39(3):413-23. PubMed ID: 24849676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2Y receptors in the mammalian nervous system: pharmacology, ligands and therapeutic potential.
    Weisman GA; Woods LT; Erb L; Seye CI
    CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):722-38. PubMed ID: 22963441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of P2Y receptors in regulating immunity and metabolism.
    Lovászi M; Branco Haas C; Antonioli L; Pacher P; Haskó G
    Biochem Pharmacol; 2021 May; 187():114419. PubMed ID: 33460626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic Signaling in Liver Pathophysiology.
    Jain S; Jacobson KA
    Front Endocrinol (Lausanne); 2021; 12():718429. PubMed ID: 34456873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uridine adenosine tetraphosphate acts as a proangiogenic factor in vitro through purinergic P2Y receptors.
    Zhou Z; Chrifi I; Xu Y; Pernow J; Duncker DJ; Merkus D; Cheng C
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H299-309. PubMed ID: 27233766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G protein-coupled purinergic P2Y receptor oligomerization: Pharmacological changes and dynamic regulation.
    Guo X; Li Q; Pi S; Xia Y; Mao L
    Biochem Pharmacol; 2021 Oct; 192():114689. PubMed ID: 34274353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geniposide attenuates inflammatory response by suppressing P2Y14 receptor and downstream ERK1/2 signaling pathway in oxygen and glucose deprivation-induced brain microvascular endothelial cells.
    Li F; Li W; Li X; Li F; Zhang L; Wang B; Huang G; Guo X; Wan L; Liu Y; Zhang S; Kang S; Ma J
    J Ethnopharmacol; 2016 Jun; 185():77-86. PubMed ID: 26976766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purinergic signaling triggers endfoot high-amplitude Ca2+ signals and causes inversion of neurovascular coupling after subarachnoid hemorrhage.
    Pappas AC; Koide M; Wellman GC
    J Cereb Blood Flow Metab; 2016 Nov; 36(11):1901-1912. PubMed ID: 27207166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of P2Y11-related purinergic signaling in inflammation and cardio-metabolic diseases.
    Dănilă MD; Piollet M; Aburel OM; Angoulvant D; Lefort C; Chadet S; Roger S; Muntean MD; Ivanes F
    Eur J Pharmacol; 2020 Jun; 876():173060. PubMed ID: 32142768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2Y purinoceptors as potential emerging therapeutical target in vascular disease.
    Schuchardt M; Tölle M; van der Giet M
    Curr Pharm Des; 2012; 18(37):6169-80. PubMed ID: 23004340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.